Loading company…
Oncotab (United States) is a company based in the United States.
OncoTAb is developing tMUC1-targeted therapies for pancreatic cancer, including a radiotheranostic and MUCD3, a bispecific T-cell engager.
OncoTAb is developing tMUC1-targeted therapies for pancreatic cancer, including a radiotheranostic and MUCD3, a bispecific T-cell engager.
Oncotab (United States) is based in the United States.
Oncotab (United States)'s website is oncotab.com.
Its website uses Apache HTTP Server, Cart Functionality, Contact Form 7, Google Font API, HashThemes Total and 9 more.